BIOSPECIFICS TECHNOLOGIES CORP Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 12 rows in 2015. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2015-08-24: Reporting owner Schamroth Michael; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2015-07-20: Reporting owner Gitman Paul; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2015-06-23: Reporting owner Gitman Paul; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2015-06-23: Reporting owner Gitman Paul; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2015-08-24 | Schamroth Michael Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −24,000 0 owned after | $4.00 exercise price | 2015-08-26 | |
| 2015-07-20 | Gitman Paul Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −8,692 0 owned after | $13.60 exercise price | 2015-07-21 | |
| 2015-06-23 | Gitman Paul Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −6,308 8,692 owned after | $13.60 exercise price | 2015-06-25 | |
| 2015-06-23 | Gitman Paul Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −15,000 0 owned after | $26.43 exercise price | 2015-06-25 | |
| 2015-06-23 | Gitman Paul Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −15,000 0 owned after | $20.00 exercise price | 2015-06-25 | |
| 2015-05-27 | Gitman Paul Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −24,000 0 owned after | $4.00 exercise price | 2015-05-28 | |
| 2015-04-22 | Chao Jennifer M Director | 4/A | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $37.64 exercise price | 2015-06-22 | |
| 2015-04-22 | Mattila Jyrki Director | 4/A | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $37.64 exercise price | 2015-06-22 | |
| 2015-04-22 | Mattila Jyrki Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $37.93 exercise price | 2015-04-23 | |
| 2015-04-22 | Chao Jennifer M Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $37.93 exercise price | 2015-04-22 | |
| 2015-01-26 | Gitman Paul Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,887 0 owned after | $1.00 exercise price | 2015-01-26 | |
| 2015-01-20 | Gitman Paul Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,113 5,887 owned after | $1.00 exercise price | 2015-01-20 |